Suppr超能文献

基于两种具有不同电解质浓度的临床可用碳酸氢林格氏溶液的BRS-A血小板添加剂溶液中洗涤血小板的储存。

Storage of washed platelets in BRS-A platelet additive solutions based on two types of clinically available bicarbonated Ringer's solutions with different electrolyte concentrations.

作者信息

Oikawa Shinji, Taguchi Takeshi, Endo Kimika, Hoshi Takahiro, Kawashima Wataru, Horibe Yasuhito, Urano Shinichi, Suzuki Ko, Minegishi Masayoshi, Itoh Takashi, Shimizu Hiroshi

机构信息

Japanese Red Cross Tohoku Block Blood Center, Sendai, Miyagi, Japan.

Japanese Red Cross Tohoku Block Blood Center, Sendai, Miyagi, Japan.

出版信息

Transfus Apher Sci. 2015 Oct;53(2):233-7. doi: 10.1016/j.transci.2015.05.002. Epub 2015 May 12.

Abstract

BACKGROUND

In Japan, no platelet (PLT) additive solutions (PASs) are officially approved for clinical use although blood centers often receive requests for washed PLTs to reduce adverse reactions. Recently, we developed a novel PAS called BRS-A based on clinically available bicarbonated Ringer's solution (BRS), Bicanate and acid-citrate-dextrose formula A (ACD-A), which has been shown to maintain the in vitro properties of PLTs in the condition of <5% residual plasma during 7-day storage. The aim of this study was to evaluate whether another clinically available BRS, Bicarbon with different electrolyte concentrations can be used as a PAS.

STUDY DESIGN AND METHODS

Two types of BRS-As were prepared by adding 25 mL of ACD-A to 500 mL of Bicanate or Bicarbon BRSs. Bicanate-based BRS-A and Bicarbon-based BRS-A contain 0.9 or 0.5 mmol/L of magnesium chloride, 95.2 or 100.1 mmol/L of sodium chloride, 4.2 or 5.1 mmol/L of trisodium citrate, and 26.6 or 23.8 mmol/L of sodium bicarbonate, respectively; the other components were identical. Apheresis PLTs stored in these solutions with less than 5% plasma for 7-day storage were compared with regard to their in vitro properties.

RESULTS

The pH levels of all units were above 7 throughout storage. The mean PLT volume, hypotonic shock response, glucose consumption, lactate production, swirling, and CD62P and CD42b expression were similar during 7-day storage. The bicarbonate levels in Bicarbon-based BRS-A were lower than those in Bicanate-based BRS-A.

CONCLUSION

Differences in concentrations of electrolytes such as magnesium, sodium, citrate, and bicarbonate salts in BRS-A do not affect the in vitro properties of PLTs during 7-day storage. These results indicate that the use of another type of BRS-A based on Bicarbon as a PAS is feasible. Thus, BRS-A can be used in hospitals that do not stock Bicanate but have Bicarbon.

摘要

背景

在日本,尽管血液中心经常收到关于洗涤血小板以减少不良反应的请求,但尚无血小板(PLT)添加剂溶液(PASs)被正式批准用于临床。最近,我们基于临床可用的碳酸氢林格氏液(BRS)、Bicanate和酸性枸橼酸盐葡萄糖配方A(ACD - A)开发了一种新型PAS,称为BRS - A,已证明其在7天储存期间血浆残留量<5%的条件下能维持血小板的体外特性。本研究的目的是评估另一种临床可用的、具有不同电解质浓度的BRS,即碳酸氢盐林格氏液(Bicarbon)是否可用作PAS。

研究设计与方法

通过向500 mL的Bicanate或Bicarbon BRSs中加入25 mL的ACD - A制备两种类型的BRS - A。基于Bicanate的BRS - A和基于Bicarbon的BRS - A分别含有0.9或0.5 mmol/L的氯化镁、95.2或100.1 mmol/L的氯化钠、4.2或5.1 mmol/L的柠檬酸钠以及26.6或23.8 mmol/L的碳酸氢钠;其他成分相同。将单采血小板储存在这些血浆含量低于5%的溶液中进行7天储存,并比较其体外特性。

结果

在整个储存期间,所有单位的pH值均高于7。在7天储存期间,平均血小板体积、低渗休克反应、葡萄糖消耗、乳酸产生、涡旋以及CD62P和CD42b表达均相似。基于Bicarbon的BRS - A中的碳酸氢盐水平低于基于Bicanate的BRS - A。

结论

BRS - A中镁、钠、柠檬酸盐和碳酸氢盐等电解质浓度的差异在7天储存期间不影响血小板的体外特性。这些结果表明,使用另一种基于Bicarbon的BRS - A作为PAS是可行的。因此,BRS - A可用于没有储备Bicanate但有Bicarbon的医院。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验